WELLS FARGO & COMPANY/MN

Position in RZLT — Rezolute, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in RZLT

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$83,673

-$127,897 QoQ

Shares Held

27,434

-69.4% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. RZLT ranks #228 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,995	$332,670,066
2	ALNY	Alnylam Pharmaceuticals, Inc.	342,763	$113,409,991
3	REGN	Regeneron Pharmaceuticals, Inc.	142,021	$109,731,102
4	HALO	Halozyme Therapeutics, Inc.	1,535,737	$99,254,679
5	INSM	INSMED Inc	597,384	$97,684,229
6	ASND	Ascendis Pharma A/S	154,199	$35,269,936
7	EXEL	Exelixis, Inc.	687,304	$29,478,466
8	ARGX	Argenx SE	38,104	$27,825,444

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$83,673	27,434	-69.4%	Shares	Defined	2026-05-11
2025-12-31	$211,570	89,649	+82.5%	Shares	Defined	2026-02-13
2025-09-30	$461,877	49,136	+37.5%	Shares	Defined	2025-11-13
2025-06-30	$159,409	35,742	+13807.4%	Shares	Defined	2025-08-14
2024-03-31	$655	257	+9.4%	Shares	Defined	2024-05-10
2023-12-31	$233	235	+5.4%	Shares	Defined	2024-02-09
2023-09-30	$294	223	-2.2%	Shares	Defined	2023-11-13
2023-06-30	$451	228	+4.1%	Shares	Defined	2023-08-15
2023-03-31	$420	219	+1.4%	Shares	Defined	2023-05-12
2022-12-31	$447	216	+12.5%	Shares	Defined	2023-02-13
2022-09-30	$526	192	-3.0%	Shares	Defined	2022-11-14
2022-06-30	$639	198	+175.0%	Shares	Defined	2022-08-12
2022-03-31	$243	72	+1.4%	Shares	Defined	2022-05-16
2021-12-31	$339	71	+153.6%	Shares	Defined	2022-02-14
2021-09-30	$209	28	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.